Global markets sag as SEC brings the hammer down on Chinese companies

Virtually all major stock indexes around the world posted losses Friday, while the SEC took action to stem the tide of Chinese companies listing in the U.S. Read More

Global markets sag as SEC brings the hammer down on Chinese companies
Virtually all major stock indexes around the world posted losses Friday, while the SEC took action to stem the tide of Chinese companies listing in the U.S. Read More
Source : Fortune More   

What's Your Reaction?

like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0

Next Article

Needham Sticks to Their Buy Rating for Bel Fuse (BELFA)

In a report released today, James Ricchiuti from Needham reiterated a Buy rating on Bel Fuse (BELFA – Research Report), with a price target of $20.00. The company's shares closed last Friday at $15.59. According to TipRanks.com, Ricchiuti is a 5-star analyst with an average return of 23.1% and a 65.9% success rate. Ricchiuti covers the Technology sector, focusing on stocks such as Benchmark Electronics, Teledyne Technologies, and Universal Display. Bel Fuse has an analyst consensus of Moderate Buy, with a price target consensus of $20.00. See today’s analyst top recommended stocks >> The company has a one-year high of $22.00 and a one-year low of $9.36. Currently, Bel Fuse has an average volume of 2,729. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Bel Fuse, Inc. engages in the design, manufacture, and marketing of products that power, protect, and connect electronic circuits. It operates through the following geographical segments: North America, Asia, and Europe. Its products include magnetic, power transformers, modules, circuit protection, fiber optic connectors, and interconnect devices. The company was founded by Elliot Bernstein in 1949 and is headquartered in Jersey City, NJ. Read More on BELFA: Barrington Keeps Their Buy Rating on Superior Uniform Group (SGC) Barrington Remains a Buy on JMP Group (JMP) VF (VFC) Receives a Buy from Pivotal Research Analysts Offer Insights on Healthcare Companies: F-star Therapeutics (FSTX) and Praxis Precision Medicines (PRAX) Rosenblatt Securities Thinks Alteryx’s Stock is Going to Recover The post Needham Sticks to Their Buy Rating for Bel Fuse (BELFA) appeared first on TipRanks Financial Blog.

In a report released today, James Ricchiuti from Needham reiterated a Buy rating on Bel Fuse (BELFA – Research Report), with a price target of $20.00. The company's shares closed last Friday at $15.59.

According to TipRanks.com, Ricchiuti is a 5-star analyst with an average return of 23.1% and a 65.9% success rate. Ricchiuti covers the Technology sector, focusing on stocks such as Benchmark Electronics, Teledyne Technologies, and Universal Display.

Bel Fuse has an analyst consensus of Moderate Buy, with a price target consensus of $20.00.

The company has a one-year high of $22.00 and a one-year low of $9.36. Currently, Bel Fuse has an average volume of 2,729.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Bel Fuse, Inc. engages in the design, manufacture, and marketing of products that power, protect, and connect electronic circuits. It operates through the following geographical segments: North America, Asia, and Europe. Its products include magnetic, power transformers, modules, circuit protection, fiber optic connectors, and interconnect devices. The company was founded by Elliot Bernstein in 1949 and is headquartered in Jersey City, NJ.

Read More on BELFA:

  • Barrington Keeps Their Buy Rating on Superior Uniform Group (SGC)
  • Barrington Remains a Buy on JMP Group (JMP)
  • VF (VFC) Receives a Buy from Pivotal Research
  • Analysts Offer Insights on Healthcare Companies: F-star Therapeutics (FSTX) and Praxis Precision Medicines (PRAX)
  • Rosenblatt Securities Thinks Alteryx’s Stock is Going to Recover

The post Needham Sticks to Their Buy Rating for Bel Fuse (BELFA) appeared first on TipRanks Financial Blog.

Source : Tip Ranks More   

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.